Table 1

Meta-analysis of the associations of baseline factors with the presence of FLAIR-HAs

FactorsNo of studies (patients)Reference number of included studies besides ENCHANTEDRisk ratio or mean difference (95% CI)Heterogeneity I2 (%)
Clinical factors
Age (year)
(with FLAIR-HAs vs without)
14 (1304) 6 9 10 23 25 31 34–38 42 43 −0.81
(−3.27 to 1.66)
61.9
Male vs female18 (1950) 6 7 9 10 13 23 29 31 33–38 42 43 48 0.94 (0.87 to 1.02)27.4
With hypertension vs without17 (1838) 6 7 9 10 13 23 29 31 33–38 42 48 0.94 (0.87 to 1.02)20.1
With DM vs without17 (1839) 6 7 9 10 13 23 29 31 33–38 42 48 0.97 (0.89 to 1.06)0.0
With dyslipidaemia vs without15 (1594) 6 7 9 10 13 23 29 31 33–37 48 1.03 (0.93 to 1.13)27.0
With AF vs without15 (1480) 9 10 12 13 23 29 31 33–35 37 42 43 48 1.17 (1.01 to 1.36)64.7
With CAD vs without6 (775) 10 31 33 42 43 1.06 (0.87 to 1.29)42.3
With prior stroke/TIA vs without6 (694) 13 23 31 43 48 0.87 (0.64 to 1.19)54.2
Smoking vs no14 (1608) 6 7 9 23 29 33–37 42 43 48 0.94 (0.85 to 1.03)17.2
Imaging factors
With proximal arterial occlusion vs without12 (1564) 7 10 12 13 23 34 38 40 42 43 48 1.88 (1.28 to 2.77)91.3
  • AF, atrial fibrillation; CAD, coronary artery disease; DM, diabetes mellitus; ENCHANTED, Enhanced Control of Hypertension and Thrombolysis Stroke Study; FLAIR-HAs, fluid-attenuated inversion recovery hyperintense arteries; TIA, transient ischaemic attack.